Colgate-Palmolive (CL) call put ratio 1 call to 2.9 puts into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Colgate-Palmolive Company (CL) PT Raised to $101 at Jefferies
July 29, 2024 6:06 AM EDTJefferies analyst Kaumil Gajrawala raised the price target on Colgate-Palmolive Company (NYSE: CL) to $101.00 (from $95.00) while maintaining a Hold rating.
The analyst comments "Colgate had to deliver a perfect qtr to sustain its 27x NTM P/E multiple. They did. Brand reinvestments are working,... More
Colgate-Palmolive Company (CL) PT Raised to $112 at Evercore ISI
July 29, 2024 5:34 AM EDTEvercore ISI analyst Robert Ottenstein raised the price target on Colgate-Palmolive Company (NYSE: CL) to $112.00 (from $106.00) while maintaining a Outperform rating.
The analyst comments "Friday, Colgates shares closed at a 30% premium to Staples, 5 points above its 20-year trading range. We do not expect CL to regress... More
Stifel on Colgate-Palmolive Company (CL): 'Lifting Estimates on Solid 2Q with Volume, EBIT Outperformance'
July 26, 2024 2:20 PM EDTStifel analyst Mark Astrachan reiterated a Buy rating and $105.00 price target on Colgate-Palmolive Company (NYSE: CL).
The analyst comments "We lift 2024-2025 EPS estimates and maintain our Buy rating and $105 price target, 17x 2025E EBITDA, following strong 2Q24 results with sales and... More

